Process-induced crystallite size and dissolution changes elucidated by a variety of analytical methods

International Journal of Pharmaceutics

Volumn 166, Issue 1, 1998, Pages 55-63

  Torrado, Guillermo ^a   Fraile, Susana ^b   Torrado, Susana ^b   Torrado, Santiago ^b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Crystallite size; Differential scanning caloriemtry; Drug dissolution; Infra red spectroscopy; Powder X ray diffraction; Recrystallization; Scanning electron microscopy

Indexed keywords

ACETYLSALICYLIC ACID; MANNITOL;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG MIXTURE; INFRARED SPECTROPHOTOMETRY; INTERMETHOD COMPARISON; MORPHOLOGY; PARTICLE SIZE; PHYSICS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TECHNIQUE; X RAY DIFFRACTION;

EID: 0032507706     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00021-0     Document Type: Article

References (15)

1. Buckton G., Choularton A., Beezer A., Chatham S. The effect of the comminution technique on the surface energy of a powder. Int. J. Pharm. 47:1988;121-128.
2. Caira M.R., Easter B., Honiball S., Horne A., Nassimbeni L.R. Structure and thermal stability of alprazolam and selected solvates. J. Pharm. Sci. 84:1995;1379-1384.
3. Connolly M., Debenedetti P.G., Tung H. Freeze crystallization of imipenem. J. Pharm. Sci. 85:1996;174-177.
4. Duddu S.P., Weller K. Importance of glass transition temperature in accelerated stability testing of amorphous solid: case study using a lyophilized aspirin formulation. J. Pharm. Sci. 85:1996;345-347.
5. Ghosh S., Ojala W.H., Gleason W.B., Grant D.J.W. Relationships between crystal structures, thermal properties and solvate stability of dialkylhydroxypyridones and their formic acid solvates. J. Pharm. Sci. 84:1995;1392-1399.
6. Grocker L.S., McCauley J.A. Comparison of the crystallinity of imipenem samples by X-ray diffraction of amorphous material. J. Pharm. Sci. 84:1995;226-227.
7. Jozwiakowski M.J., Ngugen N.T., Sisco J.M., Spancake C.W. Solubility behavior of lamivudine crystal forms in recrystallization solvents. J. Pharm. Sci. 85:1996;193-199.
8. Oguchi T., Okada M., Yonemochi E., Yamamoto K., Nakai Y. Freeze-drying of drug-additive binary systems III. Crystallization of alfa-cyclodextrin inclusion complex in freezing process. Int. J. Pharm. 61:1990;27-34.
9. Otsuka M., Onoe M., Matsuda Y. Physicochemical stability of phenobarbital polymorphs at various levels of humidity and temperature. Pharm. Res. 10:1993;577-582.
10. Saleki-Gerhardt A., Stowell J.G., Byrn S.R., Zografi G. Hydration and dehydration of crystalline and amorphous forms of raffinose. J. Pharm. Sci. 84:1995;318-322.
11. Schreiner W.N., Jenkins R. Profile fitting for quantitative analysis in X-ray powder diffraction. Adv. X-Ray Anal. 26:1983;141-148.
12. Shively M.L., Myers S. Solid-state Emulsions: the effects of process and storage conditions. Pharm. Res. 10:1993;1071-1075.
13. Torrado, S., Cadórniga, R., Torrado, J.J., 1996a. Effect of drug release rate on bioavailability of different aspirin tablets. Int. J. Pharm. 133, 65-70.
14. Torrado, S., Torrado, S., Torrado, J.J., Cadórniga R., 1996b. Preparation dissolution and characterization of albendazole solid dispersions. Int. J. Pharm. 140, 247-250.
15. Ward G.H., Schultz R.K. Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability. Pharm. Res. 12:1995;773-779.